Charles Schwab Investment Management Inc Edgewise Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$601 Billion
Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 597,603 shares of EWTX stock, worth $13.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

597,603

Previous 579,104 3.19%

Holding current value

$13.6 Million

Previous $7.59 Million 27.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$12.61 - $16.59 $233,272 - $306,898	18,499 Added 3.19%	597,603 $9.69 Million
Q2 2025 Aug 12, 2025	BUY	$11.42 - $20.13 $660,567 - $1.16 Million	57,843 Added 11.1%	579,104 $7.59 Million
Q1 2025 Sep 15, 2025	SELL	$22.0 - $30.03 $1.27 Million - $1.74 Million	-57,843 Reduced 9.99%	521,261 $11.5 Million
Q1 2025 May 09, 2025	SELL	$22.0 - $30.03 $354,156 - $483,422	-16,098 Reduced 3.0%	521,261 $11.5 Million
Q4 2024 Feb 06, 2025	BUY	$26.63 - $36.62 $406,719 - $559,297	15,273 Added 2.93%	537,359 $14.3 Million

Q3 2024 Nov 12, 2024	SELL	$15.88 - $29.5 $779,882 - $1.45 Million	-49,111 Reduced 8.6%	522,086 $13.9 Million
Q2 2024 Aug 12, 2024	BUY	$15.08 - $21.23 $1.12 Million - $1.57 Million	74,035 Added 14.89%	571,197 $10.3 Million
Q1 2024 May 08, 2024	BUY	$9.25 - $19.97 $1.54 Million - $3.32 Million	166,103 Added 50.17%	497,162 $9.07 Million
Q4 2023 Feb 06, 2024	BUY	$5.51 - $12.1 $1,102 - $2,420	200 Added 0.06%	331,059 $3.62 Million
Q3 2023 Nov 08, 2023	BUY	$5.73 - $7.69 $114,525 - $153,700	19,987 Added 6.43%	330,859 $1.9 Million
Q2 2023 Aug 09, 2023	BUY	$5.71 - $10.29 $94,563 - $170,412	16,561 Added 5.63%	310,872 $2.41 Million
Q1 2023 May 11, 2023	SELL	$6.66 - $11.33 $17,076 - $29,050	-2,564 Reduced 0.86%	294,311 $1.96 Million
Q4 2022 Feb 13, 2023	BUY	$7.58 - $11.08 $713,293 - $1.04 Million	94,102 Added 46.41%	296,875 $2.65 Million
Q3 2022 Nov 14, 2022	BUY	$8.08 - $13.58 $707,169 - $1.19 Million	87,521 Added 75.94%	202,773 $2 Million
Q2 2022 Aug 15, 2022	SELL	$5.67 - $9.87 $170,400 - $296,623	-30,053 Reduced 20.68%	115,252 $918,000
Q1 2022 May 13, 2022	BUY	$9.1 - $18.97 $44,681 - $93,142	4,910 Added 3.5%	145,305 $1.41 Million
Q4 2021 Feb 11, 2022	BUY	$14.41 - $22.41 $811,066 - $1.26 Million	56,285 Added 66.92%	140,395 $2.15 Million
Q3 2021 Nov 16, 2021	BUY	$14.11 - $24.1 $42,837 - $73,167	3,036 Added 3.74%	84,110 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$21.33 - $30.25 $1.73 Million - $2.45 Million	81,074 New	81,074 $1.73 Million

Others Institutions Holding EWTX

# of Institutions

186

Shares Held

112M

Call Options Held

188K

Put Options Held

121K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.44B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Edgewise Therapeutics, Inc. Transaction History